Progenics Pharmaceuticals Inc Asset Turnover Ratio (PGNX), as of first quarter 2020, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Progenics Pharmaceuticals Inc  (PGNX)
 

Progenics Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Progenics Pharmaceuticals Inc asset turnover ratio, the ability of Progenics Pharmaceuticals Inc's assets to generate revenue in the first quarter 2020, increased sequentially to 0.3 in the first quarter (Mar 31 2020), PGNX's balance sheet remain strong.

Within sector 117 more businesses have achieved higher asset turnover ratio. While Asset turnover ratio total ranking has improved so far during the I Quarter 2020, to 2726, from total ranking in the fourth quarter 2019 at 3209.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PGNX Asset Turnover Ratio (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter
Y / Y Asset Change -40.11 % -29.51 % -28.69 % 7.21 % 16.74 %
Y / Y Revenue Change 45.95 % 367.14 % 5.57 % 156.99 % 34.24 %
Asset Turnover Ratio (TTM) 0.3 0.25 0.15 0.14 0.1
PGNX's Total Ranking # 2726 # 3209 # 2726 # 2717 # 2675
Seq. Asset Change -17.68 % -8.14 % -14.88 % -6.96 % -3.12 %
Seq. Revenue Change -58.69 % 169.48 % -43.68 % 132.8 % 32.21 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 118
Healthcare Sector # 366
Overall Market # 2726

Asset Turnover Ratio Statistics
High Average Low
0.49 0.19 0.06
(Dec 31 2016)  




PGNX Company Profile • Back to PGNX Efficiency Comparisons • Compare PGNX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Mar 31 2020, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Mar 31 2020 Assets at quarter ending Mar 31 2020
The Pennant Group Inc   1.03 $ 352.473  Millions$ 341.979  Millions
Neurometrix Inc   1.03 $ 8.322  Millions$ 8.105  Millions
Ufp Technologies Inc   1.02 $ 199.330  Millions$ 194.569  Millions
Diversicare Healthcare Services Inc   1.01 $ 460.654  Millions$ 457.743  Millions
Lhc Group Inc   0.99 $ 2,090.527  Millions$ 2,120.074  Millions
Perspective Therapeutics Inc   0.98 $ 9.325  Millions$ 9.483  Millions
Universal Health Services Inc   0.98 $ 11,403.535  Millions$ 11,658.932  Millions
Lifeloc Technologies Inc   0.97 $ 8.701  Millions$ 8.982  Millions
Puma Biotechnology Inc   0.96 $ 224.410  Millions$ 233.084  Millions
Kushco Holdings Inc   0.96 $ 153.564  Millions$ 160.500  Millions
Acadia Healthcare Company Inc   0.95 $ 6,418.866  Millions$ 6,778.920  Millions
Seaspine Holdings Corporation  0.94 $ 159.044  Millions$ 168.967  Millions
Caredx Inc   0.94 $ 139.466  Millions$ 149.065  Millions
Orthofix Medical Inc   0.93 $ 455.666  Millions$ 488.380  Millions
Smiledirectclub Inc   0.93 $ 769.343  Millions$ 824.962  Millions
Cv Sciences Inc   0.90 $ 47.055  Millions$ 52.202  Millions
Harrow Inc   0.90 $ 50.692  Millions$ 56.458  Millions
Waters Corporation  0.89 $ 2,357.673  Millions$ 2,651.940  Millions
Accuray Incorporated  0.89 $ 405.368  Millions$ 457.524  Millions
Cytosorbents Corporation  0.88 $ 28.465  Millions$ 32.194  Millions
Pra Health Sciences Inc   0.88 $ 3,127.948  Millions$ 3,542.145  Millions
Ensign Group Inc  0.88 $ 2,076.923  Millions$ 2,357.746  Millions
Penumbra Inc  0.88 $ 556.295  Millions$ 632.355  Millions
Lantheus Holdings Inc   0.88 $ 351.531  Millions$ 400.676  Millions
Sunwin Stevia International Inc.  0.88 $ 26.091  Millions$ 29.787  Millions
Lexicon Pharmaceuticals Inc   0.88 $ 320.856  Millions$ 366.503  Millions
Cardiff Lexington Corporation  0.87 $ 4.734  Millions$ 5.450  Millions
Nevro Corp   0.87 $ 395.574  Millions$ 456.334  Millions
Vericel Corporation  0.87 $ 122.718  Millions$ 141.714  Millions
Luna Innovations Inc  0.87 $ 72.824  Millions$ 84.140  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.